We then analyzed the immune cell infiltration in the tumor microenvironment (TME) and found that the percentage of tumor-infiltrating effector CD8+ T cells, which express IFN-γ, GzmB, and CD44, was elevated in L-SeMet-treated mice (Figure 5E,F). This evidence concerns the gene CD44 and neoplasm.